The following information is about Coronary artery disease.

Coronary artery disease Defined

Are you looking for additional Vascular Disease > Coronary Artery Disease news? Try our new "Coronary Artery Disease News Focus" area.

Off-site Coronary artery disease Links, User Submitted

The following links have been collected through user bookmark submission in the Coronary artery disease category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Fri May 22

• The effect of double dose of omeprazole on the cou...[Int J Cardiol. 2008] - PubMed Result

Thu Apr 23

• Heart Disease: Heart disease is a term commonly used to refer to diseases that affect the heart. There are numerous types of heart diseases. Cardiovascular disease is another term that?s often used interchangeabl y with heart disease.

Wed Apr 15

• INSULIN RESISTANCE SYNDROME[SYNDR OME X] ~ HEALTH:THEGREA TESTGIFTOFGOD: Insulin resistance syndrome or syndrome X is a condition seen in individuals with type 2 diabetes mellitus.It is characterized by hyperglycemia[ that is the blood glucose level is raised...

Fri Mar 13

• Lipoprotein(a) - Wikipedia, the free encyclopedia
• PCIs No Better Than Medical Therapy in 'Nonacute' CAD: K: Medical Therapy best strategy for patients with non acute coronary artery disease T: Printed handout for patients

Tue Feb 17

• Sudden Cardiac Arrest (SCA) | Lower Blood Pressure: SCA is a critical emergency medical condition where the heart stops beating or fibrillates. You will die within minutes unless you receive emergency treatment

Sat Jan 10

• Coronary artery disease: Lifestyle and home remedies - MayoClinic.com

Mon Dec 8

• BEAUTIFUL Study - Morbidity-mort ality Evaluation of the If inhibitor ivabradine in patients with coronary disease and left ventricular dysfunction: The BEAUTIFUL study demonstrated that Ivabradine (Procoralan*) reduces myocardial infarction (fatal or nonfatal) (Figure 1) and revascularizat ion in coronary patients with elevated heart rate. These results were presented at the ESC Munich and published in The Lancet.
• EUROPA Trial: Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-contro lled, multicentre trial (the EUROPA study).
• Coversyl 5 mg - 10 mg: Indications: Essential hypertension. Stable coronary artery disease: reduction in risk of cardiac events in patients with a history of myocardial infarction and/or revascularizat ion. Treatment of symptomatic heart failure. Dosage and administration : Coversyl should be taken in the morning before food. Hypertension: 5 mg once daily then the dose may be increased to 10 mg after 1 month of treatment to improve blood pressure control or in case of concomitant stable coronary artery disease. Stable coronary artery disease: A starting dose of 5 mg for 2 weeks is recommended, then uptitration to 10 mg once daily, depending on acceptability. Congestive heart failure: Coversyl should be started under close medical supervision at a starting dose of 2,5 mg. This may be increased to 5 mg once blood pressure acceptability has been demonstrated. Elderly patients: start treatment at 2,5 mg daily.

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Coronary artery disease. If you would like to find related tags we recommend Tag Patterns > Coronary artery disease

Off-site Coronary Artery Disease Research Links

If you still need additional information on Coronary Artery Disease then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.